Boulder, CO, United States of America

Stephen P Eisenberg

This inventor holds 30 USPTO granted patents and 7 published patent applications, primarily in Zinc Finger Proteins. Top assignees: Sangamo Biosciences, Inc., Amgen Inc., Amgen Boulder Inc.. Active years: 1995-2016.

USPTO Granted Patents = 30 

% Patents Active = 73.3

Average Co-Inventor Count = 4.8

ph-index = 13

Forward Citations = 3,452(Granted Patents)


Company Filing History:


Years Active: 1995-2016

Loading Chart...
Areas of Expertise:
Zinc Finger Proteins
Gene Expression Regulation
Angiogenesis
Interferons
Retrovirus Inhibition
Binding Protein Design
Serine Protease Inhibitors
Nucleic Acids
Interleukin-1 Inhibitors
Optimization Methods
Targeting Sites
30 patents (USPTO):Explore Patents

Title: Stephen P. Eisenberg: Pioneer in Genetic Regulation and Protein Treatment

Introduction

Stephen P. Eisenberg is a prominent inventor based in Boulder, Colorado, with an impressive portfolio of 30 patents to his name. His work primarily focuses on biotechnology, particularly in the fields of gene expression modulation and innovative treatments for proteins, which have significant implications for therapeutic applications.

Latest Patents

Among his recent patents, one notable invention is titled "Regulation of endogenous gene expression in cells using zinc finger proteins." This invention introduces methods for modulating the expression of endogenous cellular genes by employing recombinant zinc finger proteins, showcasing Eisenberg's expertise in genetic engineering.

Another significant patent is the "High pressure treatment of aggregated interferons." This invention utilizes high-pressure techniques to treat aggregated interferons, especially recombinant human interferon-beta, aiming to reduce the aggregate content in the material. By employing various strategies, Eisenberg has demonstrated how to achieve highly pure, soluble monomeric recombinant interferon-beta. His methods, which include solubilizing, precipitating, and applying disulfide shuffling chemistry, enhance the effectiveness of high-pressure treatments, leading to biologically active solutions with improved pharmacokinetic and pharmacodynamic characteristics.

Career Highlights

Eisenberg has had a notable career, contributing his expertise to significant biotechnology firms such as Sangamo Biosciences, Inc. and Amgen Inc. His experiences in these companies have undoubtedly played a crucial role in shaping his innovative approach to addressing complex biological challenges.

Collaborations

Throughout his career, Stephen P. Eisenberg has collaborated with many talented individuals in the field. Notably, he has worked alongside Casey Christopher Case and Eric E. Jarvis, both of whom have their own remarkable contributions to biotechnology. These collaborations demonstrate his commitment to advancing scientific research and innovation.

Conclusion

In summary, Stephen P. Eisenberg is an innovative inventor known for his significant contributions to biotechnology through his patented inventions. His work on zinc finger proteins and high-pressure treatment of interferons illustrates his dedication to improving genetic regulation and therapeutic protein development. As he continues to contribute to the field, his inventions may pave the way for future advancements in medical treatments and biotechnological applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…